Disc Medicine, Inc. Increase (Decrease) in Accounts Payable
Disc Medicine, Inc. (IRON) reported Increase (Decrease) in Accounts Payable of -$2.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-30
- Disc Medicine, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$4.92M.
- Disc Medicine, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.74M.
- Disc Medicine, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.75M, a 60.18% decline year-over-year.
- Disc Medicine, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $918.00K.
- Disc Medicine, Inc. increase (decrease) in accounts payable for fiscal 2025 was $1.07M.
- Disc Medicine, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$4.68M.
- Disc Medicine, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$3.74M, a 811.22% decline from fiscal 2022.
- Disc Medicine, Inc. increase (decrease) in accounts payable for fiscal 2022 was $526.00K, a 60.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$2.18M 10-Q · filed 2026-07-30 | -$428.00K derived: sum of 3 quarters · filed 2026-07-30 | $490.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $2.74M 10-Q · filed 2026-05-05 | $4.49M derived: sum of 2 quarters · filed 2026-05-05 | $5.41M derived: sum of 3 quarters · filed 2026-05-05 | $5.09M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.67M derived: sum of 2 quarters · filed 2026-02-26 | $2.35M derived: sum of 3 quarters · filed 2026-07-30 | $1.07M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $918.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $597.00K derived: sum of 2 quarters · filed 2026-07-30 | -$680.00K 10-Q · filed 2025-11-06 | $3.71M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$1.60M 10-Q · filed 2026-07-30 | $2.80M derived: sum of 3 quarters · filed 2026-07-30 | $1.75M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$1.28M 10-Q · filed 2026-05-05 | $3.12M derived: sum of 2 quarters · filed 2026-05-05 | $2.07M derived: sum of 3 quarters · filed 2026-05-05 | $1.40M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.35M derived: sum of 2 quarters · filed 2026-02-26 | $2.68M derived: sum of 3 quarters · filed 2026-02-26 | -$4.68M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.72M derived: sum of 2 quarters · filed 2025-11-06 | -$9.08M 10-Q · filed 2025-11-06 | -$5.11M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$669.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$8.03M 10-Q · filed 2025-08-07 | -$4.06M derived: sum of 3 quarters · filed 2026-02-26 | -$294.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$7.36M 10-Q · filed 2025-05-07 | -$3.39M derived: sum of 2 quarters · filed 2026-02-26 | $375.00K derived: sum of 3 quarters · filed 2026-02-26 | -$351.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.74M derived: sum of 2 quarters · filed 2026-02-26 | $7.01M derived: sum of 3 quarters · filed 2026-02-26 | -$3.74M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.04M derived: sum of 2 quarters · filed 2024-11-12 | -$7.71M 10-Q · filed 2024-11-12 | -$7.78M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$726.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$11.48M 10-Q · filed 2024-08-08 | -$11.55M derived: sum of 3 quarters · filed 2024-08-08 | -$11.95M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$10.75M 10-Q · filed 2024-05-09 | -$10.82M derived: sum of 2 quarters · filed 2024-05-09 | -$11.23M derived: sum of 3 quarters · filed 2024-05-09 | -$9.24M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$477.00K derived: sum of 2 quarters · filed 2024-03-21 | $1.51M derived: sum of 3 quarters · filed 2024-03-21 | $526.00K 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | -$403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.58M derived: sum of 2 quarters · filed 2023-11-09 | $600.00K 10-Q · filed 2023-11-09 | -$1.81M 10-Q · filed 2022-11-10 | $2.37M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.00M 10-Q · filed 2023-08-11 | -$1.33M 10-Q · filed 2022-08-11 | $2.78M derived: sum of 3 quarters · filed 2023-08-11 | $2.28M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | -$982.00K 10-Q · filed 2023-05-15 | $2.16M 10-Q · filed 2022-05-06 | $792.00K derived: sum of 2 quarters · filed 2023-05-15 | $291.00K derived: sum of 3 quarters · filed 2023-05-15 | -$1.84M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.27M derived: sum of 2 quarters · filed 2023-03-31 | -$858.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.31M 10-K · filed 2023-03-31 | $1.56M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.63M derived: sum of 2 quarters · filed 2022-11-10 | -$459.00K 10-Q · filed 2022-11-10 | -$494.84K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $42.00K 10-Q · filed 2022-08-11 | $6.16K derived: sum of 3 quarters · filed 2022-08-11 | $45.65K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $2.17M 10-Q · filed 2022-05-06 | $2.14M derived: sum of 2 quarters · filed 2022-05-06 | $2.18M derived: sum of 3 quarters · filed 2022-05-06 | $516.65K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | -$35.84K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-29 | $3.65K 10-K · filed 2021-03-29 | -$1.66M derived: sum of 3 quarters · filed 2021-08-12 | -$2.41M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $39.49K 10-Q · filed 2020-11-12 | -$1.62M derived: sum of 2 quarters · filed 2021-08-12 | -$1.48M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$945.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $715.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |